Skip to main content

Beckman, Immune Tolerance Network Open Cell-based Assay Core Lab

NEW YORK, Sept. 27 (GenomeWeb News) - Beckman Coulter and the Immune Tolerance Network have opened a core laboratory to develop, standardize, and automate cell-based tests for clinical trials at Beckman's facility in Miami, the company said today.

 

Researchers from ITN, Beckman, and investigators from the USand Europeplan to develop and validate new cellular assays of T-cell responses for monitoring immune tolerance in clinical trials. "We believe that Beckman Coulter has a special expertise in these areas and look forward to working with the company in developing a number of these assays," said Hugh Auchincloss, chief operating officer of ITN, in a statement.

 

The Immune Tolerance Network, based at the Universityof California, San Francisco, is an international research collaboration with a dozen core facilities.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.